Press Releases

Company press releases and official corporate announcements.

A centralized feed of corporate press releases, earnings announcements, mergers, and official statements. Content is presented for informational purposes and may require additional analysis for market relevance.

Articles

10,878 total articles

Stran & Company Reports $31.2 Million in Revenue and Achieves EBITDA of $1.0 Million for the First Quarter of 2026

Stran & Company Reports $31.2 Million in Revenue and Achieves EBITDA of $1.0 Million for the First Quarter of 2026

Stran & Company, a leader in outsourced marketing solutions, reported strong Q1 2026 results with $31.2 million revenue, up 8.9% year-over-year, and positive EBITDA of $1.0 million compared to a loss in the prior year. Both core Stran and SLS segments contributed to profitability. The company expanded its client base and expects continued profitabl…

Shareholders approve all resolutions on the agendas of Tenaris’s Annual General Meeting and Extraordinary General Meeting of Shareholders

Shareholders approve all resolutions on the agendas of Tenaris’s Annual General Meeting and Extraordinary General Meeting of Shareholders

At the 2026 Annual and Extraordinary General Meetings, Tenaris shareholders approved all agenda resolutions including the consolidated financial statements for 2025, an annual dividend of $0.89 per share, director appointments, and a significant share capital reduction following cancellation of treasury shares from the third share buyback program.

Vornado JV Completes $161 Million Refinancing of 61 Ninth Avenue

Vornado JV Completes $161 Million Refinancing of 61 Ninth Avenue

Vornado Realty Trust’s joint venture secured a $161 million refinancing loan for its 61 Ninth Avenue property in Manhattan, replacing an existing $155 million loan with a longer maturity and higher interest rates tied to SOFR. The property is fully leased to major tenants Aetna and Starbucks, and the new loan matures in March 2029 with escalating m…

Nexxen to Host Investor Day on June 16, 2026

Nexxen to Host Investor Day on June 16, 2026

Nexxen International Ltd., an advertising technology company traded on NASDAQ, announced it will hold an Investor Day on June 16, 2026, in New York City. The company aims to present its strategic vision, growth prospects, financial outlook, and product innovations such as nexAI. The event will be available both in-person by invitation and via a pub…

USA Rare Earth Awarded $14.2 Million Texas Semiconductor Innovation Fund Grant to Accelerate Round Top Mountain Heavy Rare Earth Project

USA Rare Earth Awarded $14.2 Million Texas Semiconductor Innovation Fund Grant to Accelerate Round Top Mountain Heavy Rare Earth Project

USA Rare Earth, Inc. announced a $14.2 million grant award from the Texas Semiconductor Innovation Fund to expedite development of its Round Top Mountain heavy rare earth project in Texas. The project is expected to generate around 260 new jobs and over $1.4 billion in capital investment, strengthening the US rare earth supply chain essential for d…

DBV Technologies to Participate in the H.C. Wainwright 4th Annual BioConnect Investor Conference at Nasdaq

DBV Technologies to Participate in the H.C. Wainwright 4th Annual BioConnect Investor Conference at Nasdaq

DBV Technologies announced that CEO Daniel Tassé will participate in a fireside chat at the H.C. Wainwright 4th Annual BioConnect Investor Conference at Nasdaq on May 19, 2026. The company, a late-stage biopharmaceutical firm developing the VIASKIN patch for food allergies, will highlight its ongoing clinical programs targeting peanut allergies in …

Eton Pharmaceuticals to Participate in Upcoming Investor Conferences

Eton Pharmaceuticals to Participate in Upcoming Investor Conferences

Eton Pharmaceuticals, a Nasdaq-listed company specializing in treatments for rare diseases, announced that its executive management will participate in three upcoming investor conferences: B. Riley Securities, Craig-Hallum Institutional Investor, and Jefferies Global Healthcare during May and June 2026. The company has a broad portfolio of commerci…

XMax Inc. Announces Ticker Symbol Change to “XMAX”

XMax Inc. Announces Ticker Symbol Change to “XMAX”

XMax Inc. announced the upcoming change of its NASDAQ ticker symbol from 'XWIN' to 'XMAX' effective May 18, 2026. This change aligns the company's market identity with its brand and strategic expansion into artificial intelligence technologies, while continuing its furniture distribution business. The stock remains listed on NASDAQ with no sharehol…

Synaptics to Showcase Real-World Edge AI Use Cases at COMPUTEX 2026

Synaptics to Showcase Real-World Edge AI Use Cases at COMPUTEX 2026

Synaptics Incorporated announced its participation at COMPUTEX Taipei 2026 where it will showcase its AI-native compute, connectivity, and sensing technologies. The company will demonstrate advancements in Edge AI applications across smart home, industrial automation, and enterprise sectors, emphasizing real-time decision-making and device-level pr…

Fold Holdings, Inc. (NASDAQ: FLD) Announces First Quarter 2026 Results

Fold Holdings, Inc. (NASDAQ: FLD) Announces First Quarter 2026 Results

Fold Holdings, Inc. reported its Q1 2026 financial results with revenues of $5.6 million, down 21.1% year-over-year, and a net loss of $29.2 million. The company experienced a 32% decrease in transaction volumes driven by challenging Bitcoin market conditions. Despite these headwinds, Fold is progressing with its Bitcoin Rewards Credit Card, now wi…

Alignment Healthcare Strengthens Leadership Team to Support Long-Term Growth and Shareholder Value Creation

Alignment Healthcare Strengthens Leadership Team to Support Long-Term Growth and Shareholder Value Creation

Alignment Healthcare announced key leadership changes including CEO John Kao assuming the additional role of Chairman, the appointment of Joseph Konowiecki as Executive Vice President of Corporate Affairs, and new hires Mark Kent as President of its Management Services Organization and Shane Hochradel as COO. These moves aim to strengthen the compa…

Upexi Reports Fiscal Third Quarter 2026 Financial Results

Upexi Reports Fiscal Third Quarter 2026 Financial Results

Upexi, Inc. reported its fiscal Q3 2026 results showing a 9% increase in Solana tokens held, $3.5 million digital asset revenue, and a total revenue of $4.6 million. Despite revenue growth, the company reported a net loss of $109.3 million primarily due to significant unrealized losses on digital assets. Operational focus includes share repurchases…

AH Realty Trust Announces Quarterly Dividend

AH Realty Trust Announces Quarterly Dividend

AH Realty Trust announced its regular quarterly cash dividend of $0.14 per common share and a cash dividend of $0.421875 per share on its 6.75% Series A Cumulative Redeemable Perpetual Preferred Stock, payable in July 2026. The company is a REIT focusing on retail and office assets in the Mid-Atlantic and Southeastern US.

Kayne Anderson Energy Infrastructure Fund Announces Appointment of Michael J. Hennigan as New Independent Director

Kayne Anderson Energy Infrastructure Fund Announces Appointment of Michael J. Hennigan as New Independent Director

Kayne Anderson Energy Infrastructure Fund, a NYSE-listed closed-end management investment company focused on energy infrastructure, announced the appointment of Michael J. Hennigan as an independent director. Mr. Hennigan brings decades of leadership experience in refining and midstream energy sectors, having held CEO roles at Marathon Petroleum an…

Orchestra BioMed Reports First Quarter 2026 Financial Results and Highlights Recent Business Updates

Orchestra BioMed Reports First Quarter 2026 Financial Results and Highlights Recent Business Updates

Orchestra BioMed reported first quarter 2026 financial results highlighting progress in its pivotal clinical trials for AVIM Therapy and Virtue SAB. The company targets enrollment completion for the BACKBEAT Trial by Q3 2026, plans a late-breaking clinical presentation in Q2 2027, and aims for regulatory submissions thereafter, supported by FDA Bre…

Palisade Bio Reports First Quarter 2026 Financial Results and Highlights Continued Clinical Progress of PALI-2108

Palisade Bio Reports First Quarter 2026 Financial Results and Highlights Continued Clinical Progress of PALI-2108

Palisade Bio, a clinical-stage biopharmaceutical company, announced its first quarter 2026 financial results and highlighted continued clinical progress of its lead PDE4 inhibitor prodrug PALI-2108 for treating inflammatory bowel disease (IBD). The company plans to initiate Phase 2 trials for ulcerative colitis in Q3 2026 and Crohn's disease in ear…

DoubleDown Interactive First Quarter 2026 Revenue Rises 12.7% and Earnings per Fully Diluted Common Share Increases 48.4%

DoubleDown Interactive First Quarter 2026 Revenue Rises 12.7% and Earnings per Fully Diluted Common Share Increases 48.4%

DoubleDown Interactive, a Nasdaq-listed digital games company, announced robust first quarter 2026 financial results with revenues increasing 12.7% year-over-year to $94.1 million and earnings per diluted share rising 48.4% to $14.28. Growth was driven by the integration of WHOW Games, expansion in Direct-to-Consumer revenue, and increased performa…

BROOKFIELD BANCSHARES, INC. AND FIRST NATIONAL BANK OF BROOKFIELD ANNOUNCE EXECUTION OF MERGER AGREEMENT TO ACQUIRE NSTS BANCORP, INC. AND NORTH SHORE TRUST AND SAVINGS

BROOKFIELD BANCSHARES, INC. AND FIRST NATIONAL BANK OF BROOKFIELD ANNOUNCE EXECUTION OF MERGER AGREEMENT TO ACQUIRE NSTS BANCORP, INC. AND NORTH SHORE TRUST AND SAVINGS

Brookfield Bancshares, Inc., the holding company for First National Bank of Brookfield, has agreed to acquire NSTS Bancorp, Inc. in an all-cash transaction valued at $73.7 million. NSTS shareholders will receive $14.28 per share. The merger expands Brookfield's footprint in the Chicago-Naperville-Elgin metropolitan area, combining assets of over $6…